about
Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures.The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.The role of infections in Behçet disease and neuro-Behçet syndrome.Neurosarcoidosis according to Zajicek and Scolding criteria: 15 probable and definite cases, their treatment and outcomes.Concurrent autoimmune hepatitis in multiple sclerosis.Inflammatory myopathy associated with myasthenia gravis with and without thymic pathology: Report of four cases and literature review.The vitamin D receptor gene FokI polymorphism and Multiple Sclerosis in a Northern Portuguese population.Myasthenia gravis in pregnancy: Experience of a portuguese center.Characteristics of Neuro-Behçet's Disease in a Case-Series from a Single Centre in Northern Portugal.Cognitive reserve in multiple sclerosis: Protective effects of education.Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.Neurolymphomatosis mimicking neurosarcoidosis: a case report.Graves' disease presenting as pseudotumor cerebri: a case report.Cognitive functioning in Behçet's disease.Frequent involvement of central nervous system in primary Sjögren syndrome.Influence of pregnancy on neuromyelitis optica spectrum disorder.Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.Lambert-Eaton myasthenic syndrome and prostatic adenocarcinoma.Myasthenia gravis and pregnancy: anaesthetic management--a series of cases.Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease.Are cognitive and olfactory dysfunctions in neuropsychiatric lupus erythematosus dependent on anxiety or depression?Atypical posterior reversible encephalopathy syndrome: a flare of systemic lupus erythematosus.Olfactory dysfunction in multiple sclerosis: association with secondary progression.Treatment of refractory neurosarcoidosis with Infliximab.Hypnic Headache and Basilar Artery Dolichoectasia.Myasthenia gravis with systemic and neurological polyautoimmunity.Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal.MuSK myasthenia gravis and pregnancy.Recurrent cerebrospinal fluid escape in an HIV-1-infected patient receiving antiretroviral therapy.Late onset vanishing white matter disease presenting with learning difficulties.Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis.HLA and age of onset in myasthenia gravisThe role of KIR2DS1 in multiple sclerosis - KIR in Portuguese MS patientsHFE gene polymorphisms and severity in Portuguese patients with multiple sclerosisReversible cerebral vasoconstriction syndrome presenting with haemorrhageEyelid opening apraxia in an AIDS patientSpontaneous remission lasting 3 decades in myelin oligodendrocyte glycoprotein disease
P50
Q33396284-04469DD0-D31E-435C-A504-BDA955DDA060Q36271927-7E5B6E02-44CF-4A91-BBAC-2AA309312C4BQ36515512-2A32D37E-C1BE-43E6-A6E0-ECD89B9294ADQ38377131-0D9A548E-C052-4FF3-B6C1-374FB5E5C7CBQ38675187-571DBBAB-F3D5-4287-ABBF-E9A6986CC39CQ38920490-764099C3-1EC3-4B97-8984-53942011E7E8Q39245898-4296932B-F94E-4815-B9B7-CAD9A6F41F8DQ40165044-E06C0AA9-E935-4C77-BE5F-FB74EB3A10E9Q40878816-FC3AD144-6BEA-4287-9B3A-5C3BDEE2ADD6Q40915108-8D395206-3431-49A0-A168-48695461A42DQ40967590-6C6FDEEB-935B-4C57-92E8-916DF074788AQ41744297-6B476DE1-7CBA-4B18-8653-BBE101945C12Q41964308-8E508C90-7AAF-4288-A231-3CDE659E15BEQ42128029-1E40B12A-2B27-43B7-A9AF-A21722AD10F2Q43275862-8127D93E-8621-48C9-8745-18DF7AC463D1Q43629235-EDCAA8A4-6DF2-49BA-A202-1EE481481BCBQ45774295-4ADCA451-4B9B-4CF9-9182-7FEF678C153CQ47687523-BCE3C9D3-9646-4FDB-B554-A24DF0C56C68Q48162535-6BD40430-DD42-43EC-B574-F0D9B86BC88BQ48333213-E38D86FE-77F7-4216-B0C4-E2237D58F043Q48690367-83C5CDFB-F7EB-4AF9-B25F-27B8C6EFF8C2Q48720686-767ADB97-E8DD-4F24-A865-F71820E16996Q48735137-328AD67A-DA4B-4C3D-B6A6-5A75E65A240BQ48824784-9CDA2D19-254E-4F9B-8051-217E0E3E8301Q48853010-E90C1516-1A3C-418C-9242-D94A88B1E3FCQ48900615-884B7B32-A438-4877-AB1B-0C4924E93B64Q49387969-D4618719-80E8-4E8A-BC3D-1713754DA9C9Q49813869-ADFCDA8C-04DA-4EF9-AFD8-172C23050ACEQ50118115-603B0ED9-2CC1-40D5-B7D3-903A17897692Q50877066-25257081-C62E-476C-9B86-55E04F7C510DQ50984127-7FF2870A-1BBE-47D2-877E-C81EA1BE367DQ55043117-23F65375-7A06-42C8-A8A3-F309FC93194CQ57526155-C2F5BF47-BE54-434C-9CF6-59F19A8221CCQ57526190-8CF9251D-4768-41AC-B1FA-3ADFEF6DFD40Q57526223-2A828A34-AFEE-4BA9-AD1F-F6CA863A65DDQ60991405-5FE94325-ED04-4379-8EE4-4541BF8EDBC0Q60991408-819E5563-4A55-4B0A-A386-ED745B48ED37Q89639300-AD644741-46FB-4947-844A-B5AC0C731358
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ernestina Santos
@ast
Ernestina Santos
@en
Ernestina Santos
@es
Ernestina Santos
@nl
Ernestina Santos
@sl
type
label
Ernestina Santos
@ast
Ernestina Santos
@en
Ernestina Santos
@es
Ernestina Santos
@nl
Ernestina Santos
@sl
prefLabel
Ernestina Santos
@ast
Ernestina Santos
@en
Ernestina Santos
@es
Ernestina Santos
@nl
Ernestina Santos
@sl
P106
P1153
15127909600
57195719812
P21
P31
P496
0000-0003-4053-8940